Copyright
©The Author(s) 2021.
World J Transplant. Jun 18, 2021; 11(6): 147-160
Published online Jun 18, 2021. doi: 10.5500/wjt.v11.i6.147
Published online Jun 18, 2021. doi: 10.5500/wjt.v11.i6.147
Pre-transplant | Post-transplant | |
No lower age limit for screening | Diabetes | Screen for post-transplant diabetes |
Consider earlier cardiologist referral | Consider using any oral antihyperglycemic including newer agents | |
Use oral glucose tolerance test/HbA1c | Hypertension | Consider using any antihypertensive agent |
Maximize cardioprotective medication | Consider vitamin D deficiency | |
Monitor for adherence | ||
Dyslipidemia | Recognize that lipid profiles do not necessarily reflect increased cardiovascular risk | |
Monitor HDL cholesterol and triglycerides | ||
Recognize potential for increased exposure from standard statin doses | ||
Obesity and metabolic syndrome | Monitor waist-hip ratio | |
Target counseling about potential weight gain and abdominal girth increase even if body mass index is normal | ||
Screen for presence of metabolic syndrome | ||
Target interventions to individual components of metabolic syndrome | ||
Health behavior | Decrease carbohydrate and saturated fat intake | |
Increase monounsaturated fat and fiber intake | ||
Implement structured, graded exercise programs |
- Citation: Prasad GVR, Bhamidi V. Managing cardiovascular disease risk in South Asian kidney transplant recipients. World J Transplant 2021; 11(6): 147-160
- URL: https://www.wjgnet.com/2220-3230/full/v11/i6/147.htm
- DOI: https://dx.doi.org/10.5500/wjt.v11.i6.147